ToxSci Advance Access published online on May 28, 2003
Toxicological Sciences, doi:10.1093/toxsci/kfg137
Toxicological Sciences © Society of Toxicology 2003; all rights reserved
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 School of Life Sciences, Lanzhou University, Lanzhou, Gansu 730000, China
* To whom correspondence should be addressed. E-mail: kangjiuhong{at}lzu.edu.cn.
The carcinogenicity of specific insoluble nickel compounds is mainly due to their intracellular generation of Ni2+ ion and its suppression on gene transcription, while the inhibition of Ni2+ on histone acetylation plays an important role in the suppression or silencing of genes. Recent studies on Ni2+ and histone H4 acetylation suggest that Ni2+ inhibits the acetylation of histone H4 through binding with its N-terminal Histidine-18. It is well known that bound-Ni2+ readily produces reactive oxygen species (ROS) in vivo, a critical factor inversely related with the occurrence of resistance of mammalian cells to Ni2+. Thus we tried to find the possible role of ROS in the induction of Ni2+ on histone acetylation in present study. We found that a high concentration of Ni2+ (no less than 600 µM) caused a significant decrease of histone acetylation in human hepatoma cells. This inhibition was shown to result mainly from the influence of Ni2+ on the overall histone acetyltransferase (HAT) activity indicated by the histone acetylation assay with the presence of a specific histone deacetylase (HDAC) inhibitor, trichostatin A (TSA). The in vitro HAT and HDAC assays further confirmed this result. At the same time, we found that the exposure of hepatoma cells to Ni2+ generated ROS. Co-administration of hydrogen peroxide with Ni2+ generated more ROS and more histone acetylation inhibition. Addition of the antioxidants, 2-mercaptoethanol (2-ME) at 2 mM or N-acetyl-cysteine (NAC) at 1 mM, with Ni2+ together completely suppressed ROS generation and significantly diminished the induced histone hypoacetylation. The data presented here prove that the ROS generation plays a role in the inhibition of histone acetylation, and hence the gene suppression and carcinogenesis caused by Ni2+ exposure, providing a new door for us to continuously understand the mechanism of ROS in the carcinogenicity of Ni2+ and the resistance of mammalian cells to Ni2+.
© 2003 Society of Toxicology
Carcinogenicity
Nickel-Induced Histone Hypoacetylation: The Role of Reactive Oxygen Species
2 Department of Hematology, General Hospital of Lanzhou, Gansu 730000, China
3 Institut de Topologie de Dynamique des Systemes, CNRS ESA 7986, Universite Paris7-Denis-Diderot,1, rue Guy de la Brosse, 75005 Paris, France
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Q. Ke, Q. Li, T. P. Ellen, H. Sun, and M. Costa Nickel compounds induce phosphorylation of histone H3 at serine 10 by activating JNK-MAPK pathway Carcinogenesis, June 1, 2008; 29(6): 1276 - 1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cui, J. Miao, and L. Cui Cytotoxic Effect of Curcumin on Malaria Parasite Plasmodium falciparum: Inhibition of Histone Acetylation and Generation of Reactive Oxygen Species Antimicrob. Agents Chemother., February 1, 2007; 51(2): 488 - 494. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ding, X. Zhang, J. Li, L. Song, W. Ouyang, D. Zhang, C. Xue, M. Costa, J. A. Melendez, and C. Huang Nickel Compounds Render Anti-apoptotic Effect to Human Bronchial Epithelial Beas-2B Cells by Induction of Cyclooxygenase-2 through an IKKbeta/p65-dependent and IKK{alpha}- and p50-independent Pathway J. Biol. Chem., December 22, 2006; 281(51): 39022 - 39032. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Ke, T. Davidson, H. Chen, T. Kluz, and M. Costa Alterations of histone modifications and transgene silencing by nickel chloride Carcinogenesis, July 1, 2006; 27(7): 1481 - 1488. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chen, Q. Ke, T. Kluz, Y. Yan, and M. Costa Nickel Ions Increase Histone H3 Lysine 9 Dimethylation and Induce Transgene Silencing Mol. Cell. Biol., May 15, 2006; 26(10): 3728 - 3737. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Dashwood, M. C. Myzak, and E. Ho Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention? Carcinogenesis, February 1, 2006; 27(2): 344 - 349. [Abstract] [Full Text] [PDF] |
||||



